The major membrane phospholipid, PC, which serves as PLA2 substrate, showed a trend for reduction in both erythrocyte membranes and plasma from MS patients, although the observed differences were not statistically significant ( Figure 1 A,B).
← all excerpts
Sphingolipid Catabolism and Glycerophospholipid Levels Are Altered in Erythrocytes and Plasma from Multiple Sclerosis Patients.
1
—
—